Clinical trial
Molecular Breast Imaging: A Novel Technology for Detection of Malignant Breast Lesions.
NCT01004666 is registered in ClinicalTrials.gov with Tel-Aviv Sourasky Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecular Breast Imaging: A Novel Technology for Detection of Malignant Breast Lesions.
- Lead sponsor
- Tel-Aviv Sourasky Medical Center
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 31, 2009
- Completion date
- October 31, 2015
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dense breast tissue, discrepancy with clinical examination, equivocal mammographic, sonographic or mri lesion, small breast lesions